Title: Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective
Authors: Ludwig, Heinz ×
Beksac, Meral
Blade, Joan
Cavenagh, Jamie
Cavo, Michele
Delforge, Michel
Dimopoulos, Meletios
Drach, Johannes
Einsele, Hermann
Facon, Thierry
Goldschmidt, Hartmut
Harousseau, Jean-Luc
Hess, Urs
Kropff, Martin
da Costa, Fernando Leal
Louw, Vernon
Magen-Nativ, Hila
Mendeleeva, Larisa
Nahi, Hareth
Plesner, Torben
San-Miguel, Jesus
Sonneveld, Pieter
Udvardy, Miklos
Sondergeld, Pia
Palumbo, Antonio #
Issue Date: 2011
Publisher: AlphaMed Press
Series Title: The Oncologist vol:16 issue:4 pages:388-403
Abstract: The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with data to make evidence-based decisions regarding the optimal management of patients. This review is an update to a previous summary of European treatment practices that examines new data that have been published or presented at congresses up to the end of 2010 and assesses their impact on treatment practices. The Oncologist 2011;16:388-403
ISSN: 1083-7159
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Hematology Section (-)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science